Entheon Biomedical (ENBI) Stock Statistics & Valuation Metrics

Entheon Biomedical has a market cap or net worth of C$1.39M. The enterprise value is C$934.39K.

Entheon Biomedical has 13,858,926 shares outstanding. The number of shares has decreased by -2.65% in one year.

Entheon Biomedical’s return on equity (ROE) is -2.19 and return on invested capital (ROIC) is -198.42%.

The current PE Ratio of Entheon Biomedical is ―. Entheon Biomedical’s PEG ratio is 0.18.

In the last 12 months, Entheon Biomedical had revenue of 0.00 and earned -318.00K in profits. Earnings per share was -0.04.

In the last 12 months, operating cash flow was -346.39K and capital expenditures 0.00, giving a free cash flow of -346.39K billion.

Entheon Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Entheon Biomedical upcoming earnings date is Mar 31, 2026, After Close (Confirmed).

Entheon Biomedical as a current ratio of 10.41, with Debt / Equity ratio of 0.00%

In the past 12 months, Entheon Biomedical has paid 0.00 in taxes.

Entheon Biomedical EV to EBITDA ratio is -2.98, with an EV/FCF ratio of -2.66.

Entheon Biomedical has C$382.21K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$382.21K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Entheon Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―